Literature DB >> 17252699

Mosaic Turner syndrome and hyperinsulinaemic hypoglycaemia.

Haya Alkhayyat1, Henrik B T Christesen, James Steer, Helen Stewart, Klaus Brusgaard, Khalid Hussain.   

Abstract

BACKGROUND: A common and well recognised feature of Turner's syndrome (partial or total monosomy X) is impaired glucose tolerance or type 2 diabetes mellitus. A small percentage of patients with Turner's syndrome have a complex mosaic karyotype with atypical clinical features and mental retardation. METHODS/PATIENT: We report the first case of a child with a complex mosaic Turner genotype and hyperinsulinaemic hypoglycaemia responsive to diazoxide therapy.
RESULTS: Cytogenetic analysis showed four cell lines: one with 45,X; the others with an additional small ring chromosome, a small marker chromosome, and both the ring and marker chromosomes, respectively. FISH studies showed the abnormal chromosomes to originate from an X. The X inactivation locus (XIST) was present in the ring, but not in the marker chromosome.
CONCLUSIONS: The recognition of hypoglycaemia in children with atypical Turner's syndrome is important as persistent hypoglycaemia may lead to brain damage in addition to the risk of mental retardation. Further studies are required to understand whether the mosaic over--or underexpression of unidentified X chromosome gene(s) in the pancreatic beta-cells leads to hyperinsulinaemic hypoglycaemia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17252699     DOI: 10.1515/jpem.2006.19.12.1451

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  10 in total

Review 1.  Approach to hypoglycemia in infants and children.

Authors:  Kajal Gandhi
Journal:  Transl Pediatr       Date:  2017-10

Review 2.  Perspective on the Genetics and Diagnosis of Congenital Hyperinsulinism Disorders.

Authors:  Charles A Stanley
Journal:  J Clin Endocrinol Metab       Date:  2016-02-23       Impact factor: 5.958

Review 3.  Management strategies for neonatal hypoglycemia.

Authors:  Courtney B Sweet; Stephanie Grayson; Mark Polak
Journal:  J Pediatr Pharmacol Ther       Date:  2013-07

Review 4.  Hyperinsulinemic hypoglycemia: clinical, molecular and therapeutical novelties.

Authors:  Arianna Maiorana; Carlo Dionisi-Vici
Journal:  J Inherit Metab Dis       Date:  2017-06-27       Impact factor: 4.982

Review 5.  Hyperinsulinaemic hypoglycaemia: genetic mechanisms, diagnosis and management.

Authors:  Senthil Senniappan; Balasubramaniam Shanti; Chela James; Khalid Hussain
Journal:  J Inherit Metab Dis       Date:  2012-01-10       Impact factor: 4.982

Review 6.  The Diagnosis and Management of Hyperinsulinaemic Hypoglycaemia.

Authors:  Klára Roženková; Maria Güemes; Pratik Shah; Khalid Hussain
Journal:  J Clin Res Pediatr Endocrinol       Date:  2015-06

7.  Hyperinsulinemic Hypoglycaemia in a Turner Syndrome with Ring (X).

Authors:  Michela Cappella; Vanna Graziani; Antonella Pragliola; Alberto Sensi; Khalid Hussain; Claudia Muratori; Federico Marchetti
Journal:  Case Rep Pediatr       Date:  2015-04-29

8.  Comprehensive screening shows that mutations in the known syndromic genes are rare in infants presenting with hyperinsulinaemic hypoglycaemia.

Authors:  Thomas W Laver; Matthew N Wakeling; Janet Hong Yeow Hua; Jayne A L Houghton; Khalid Hussain; Sian Ellard; Sarah E Flanagan
Journal:  Clin Endocrinol (Oxf)       Date:  2018-09-20       Impact factor: 3.478

Review 9.  Congenital Hyperinsulinism: Current Laboratory-Based Approaches to the Genetic Diagnosis of a Heterogeneous Disease.

Authors:  Thomas I Hewat; Matthew B Johnson; Sarah E Flanagan
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-07       Impact factor: 6.055

10.  Congenital Hyperinsulinism in Infants with Turner Syndrome: Possible Association with Monosomy X and KDM6A Haploinsufficiency.

Authors:  Christopher E Gibson; Kara E Boodhansingh; Changhong Li; Laura Conlin; Pan Chen; Susan A Becker; Tricia Bhatti; Vaneeta Bamba; N Scott Adzick; Diva D De Leon; Arupa Ganguly; Charles A Stanley
Journal:  Horm Res Paediatr       Date:  2018-06-14       Impact factor: 2.852

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.